Big investments in biomanufacturing capacity are paying off for Samsung Biologics as it significantly increases production deals with Big Pharma clients. Within the past two weeks, Samsung Biologics has announced major contract expansions with both Pfizer and Novartis. Having inked a deal with Pfizer worth KRW 241 billion ($182 million) back in March, the contract development and manufacturing organization (CDMO) revealed in a filing this has more than doubled to $375 million. A second contract focused on biosimilars worth $411…

ABEC will deliver multiple Customer Single Run (CSR) single-use systems to Eli Lilly’s manufacturing facility in Limerick, Ireland. Eli Lilly announced plans to build a €400+ million ($433 million) greenfield site in Limerick, Ireland last year. The firm then magnified the investment to around $1 billion to further support its biologics ambition in the country . in March. Now, Lilly has selected ABEC, a solutions and services for biotech manufacturing to support Basis of Design (BOD) engineering of the plant’s upstream…